Insights

Drug safety excellence in PSP selection

Meet the Expert: Mary Speagle

Key considerations for drug safety compliance in a PSP

Meet the Expert: Joanne Baxby

Case study: Innomar’s role in addressing a critical drug shortage

The value of RWE collected through PSPs

Case study: Enabling shared access - Digitized solutions to increase visibility and facilitate streamlined communication between a patient support program (PSP) and manufacturer

Transforming Patient Support Program (PSP) enrolment to enhance user experiences and optimize workflows

Manufacturers

Patient support programs: A significant source of real-world data

Unlocking Access Building a National Strategy to Support Canadians with Rare Diseases

Manufacturers

Commercializing cell and gene therapies in Canada

Manufacturers

Digital innovation in patient support

Manufacturers

Insight Series: The Value of Real-World Evidence in Canadian Drug Commercialization – Part 1

Manufacturers

Insight Series: Value of Patient Support Programs for Specialty Medications in Canada

Improved Health Outcomes in Patients Receiving Health Case Management

Understanding the Journey of a Person with a Rare Disease

Case Study: Patient-centric Care in Rare Disease

Future of Patient Support Programs in Canada

Case Study: Discovering New Opportunities for Growth in a Niche Market

Case Study: Leveraging Physician Relationships to Co-create Patient Support

Case Study: Optimizing a Patient Support Program to Improve Therapy Adherence

Support Programs Designed to Assist Patients and Their Families

Nurse-led Health Case Management